Author Page for Rena Conti

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

Pricing in the Market for Anticancer Drugs

NBER Working Paper No. w20867

Number of pages: 34 Posted: 20 Jan 2015

David H. Howard, Peter Bach, Ernst R. Berndt and Rena Conti

Emory University - Department of Health Policy and Management, Memorial Sloan Kettering Cancer Center - Department of Medicine, Massachusetts Institute of Technology (MIT) - Sloan School of Management and University of Chicago

Downloads 28 (353,205)

Abstract:

Specialty Drug Prices and Utilization after Loss of U.S. Patent Exclusivity, 2001-2007

NBER Working Paper No. w20016

Number of pages: 48 Posted: 31 Mar 2014

Rena Conti and Ernst R. Berndt

University of Chicago and Massachusetts Institute of Technology (MIT) - Sloan School of Management

Downloads 25 (394,428)

Abstract:

The Effect of Fda Advisories on Branded Pharmaceutical Firms' Valuations and Promotion Efforts

NBER Working Paper No. w17528

Number of pages: 27 Posted: 22 Oct 2011

Rena Conti, Haiden Huskamp and Ernst R. Berndt

University of Chicago, affiliation not provided to SSRN and Massachusetts Institute of Technology (MIT) - Sloan School of Management

Downloads 8 (489,513)

Rena Conti

University of Chicago

3

79

0

Scholarly Papers (3)

Pricing in the Market for Anticancer Drugs

Abstract:

Specialty Drug Prices and Utilization after Loss of U.S. Patent Exclusivity, 2001-2007

Abstract:

The Effect of Fda Advisories on Branded Pharmaceutical Firms' Valuations and Promotion Efforts

Abstract:

Quick Links

Rankings

About